1. Home
  2. HOWL vs AIRG Comparison

HOWL vs AIRG Comparison

Compare HOWL & AIRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • AIRG
  • Stock Information
  • Founded
  • HOWL 2017
  • AIRG 1995
  • Country
  • HOWL United States
  • AIRG United States
  • Employees
  • HOWL N/A
  • AIRG N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • AIRG Radio And Television Broadcasting And Communications Equipment
  • Sector
  • HOWL Health Care
  • AIRG Technology
  • Exchange
  • HOWL Nasdaq
  • AIRG Nasdaq
  • Market Cap
  • HOWL 47.1M
  • AIRG 48.7M
  • IPO Year
  • HOWL 2021
  • AIRG 2016
  • Fundamental
  • Price
  • HOWL $1.36
  • AIRG $5.04
  • Analyst Decision
  • HOWL Strong Buy
  • AIRG Strong Buy
  • Analyst Count
  • HOWL 3
  • AIRG 3
  • Target Price
  • HOWL $8.33
  • AIRG $8.50
  • AVG Volume (30 Days)
  • HOWL 554.2K
  • AIRG 42.1K
  • Earning Date
  • HOWL 08-07-2025
  • AIRG 08-06-2025
  • Dividend Yield
  • HOWL N/A
  • AIRG N/A
  • EPS Growth
  • HOWL N/A
  • AIRG N/A
  • EPS
  • HOWL N/A
  • AIRG N/A
  • Revenue
  • HOWL $1,143,000.00
  • AIRG $58,381,000.00
  • Revenue This Year
  • HOWL N/A
  • AIRG N/A
  • Revenue Next Year
  • HOWL N/A
  • AIRG $23.54
  • P/E Ratio
  • HOWL N/A
  • AIRG N/A
  • Revenue Growth
  • HOWL N/A
  • AIRG 8.46
  • 52 Week Low
  • HOWL $0.60
  • AIRG $3.17
  • 52 Week High
  • HOWL $4.18
  • AIRG $10.34
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 60.96
  • AIRG 64.50
  • Support Level
  • HOWL $1.25
  • AIRG $4.19
  • Resistance Level
  • HOWL $1.44
  • AIRG $5.71
  • Average True Range (ATR)
  • HOWL 0.10
  • AIRG 0.43
  • MACD
  • HOWL 0.02
  • AIRG 0.08
  • Stochastic Oscillator
  • HOWL 68.89
  • AIRG 52.07

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About AIRG Airgain Inc.

Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.

Share on Social Networks: